VVT Med advances Portugal entry as Dermworks starts ScleroSafe evaluation
VVT Med says Dermworks will begin ScleroSafe® market evaluation, with initial physician demonstrations and market research planned following earlier independent physician experience in Portugal.
Initial Order Supplied to Dermworks; Market Research and Initial Physician Demonstrations to Begin Following Earlier Independent Physician Experience in PortugalVANCOUVER, BC, Sept.
1, 2026 /CNW/ -- VVT Med Inc. (TSXV:VVTM) ("VVT Med" or the "Company"), a developer of minimally invasive, non-therma…